DAWN GRIST: Open Payments
NPI 1720660129 · DERRY, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$602 in 25 payments from 11 companies in 2025. Trend: 2023 $450 · 2024 $478 · 2025 $602
Food & beverage: $602
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $186 |
| Teva Pharmaceuticals USA, Inc. | 3 | $90 |
| Lundbeck LLC | 3 | $78 |
| E.R. Squibb & Sons, L.L.C. | 2 | $56 |
| Janssen Pharmaceuticals, Inc | 2 | $48 |
| ABBVIE INC. | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Brainsway USA INC | 1 | $23 |
| Alkermes, Inc. | 1 | $23 |
Products named: ABILIFY MAINTENA, REXULTI, UZEDY, COBENFY, SPRAVATO, VRAYLAR, ABILIFY ASIMTUFII, CAPLYTA.
Industry payments across NH — which companies pay providers there.
